|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/42 | (2006.01) |
| C07K 16/4208 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Number of the document | 3464383 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17730936.6 |
| Date of filing the European patent application | 2017-05-24 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/053066 |
| Date | 2017-05-24 |
| (87) | Number | WO 2017/203450 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 201662341574 P | 2016-05-25 | US | |
| 201662438754 P | 2016-12-23 | US |
| (72) |
EWERT, Stefan , CH
KHDER, Yasser , CH
KOCH, Alexander , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF |
| REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF |